Management of opioid use disorder: 2024 update to the national clinical practice guideline
Igor Yakovenko(British Columbia Centre on Substance Use), Julie Bruneau(Inserm), Thomas D. Brothers(Dalhousie University), Ginette Poulin(British Columbia Centre on Substance Use), Marie-Ève Goyer(British Columbia Centre on Substance Use), Rehm Jürgen(British Columbia Centre on Substance Use), Peter Selby(Centre for Addiction and Mental Health), David C. Hodgins(University of Calgary), Sherry H. Stewart(Dalhousie University), Evan Wood(University of British Columbia), Yvette Mukaneza(British Columbia Centre on Substance Use), Katuschia Germé(British Columbia Centre on Substance Use), Jacob Belliveau(Centre Hospitalier de l’Université de Montréal), Ross Fraleigh(British Columbia Centre on Substance Use), Paxton Bach(University of British Columbia)
Cited by 40
Related Papers
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection
|Hepatology|2013|397
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States
|Applied and Environmental Microbiology|2006|238
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
|The Lancet Infectious Diseases|2018|228
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity
|AIDS|2015|174
Efficacy of brief coping skills interventions that match different personality profiles of female substance abusers.
|Psychology of Addictive Behaviors|2000|157